-
Immuno-oncology Market Huge Growth in Future Scope 2023-2030 | AbbVie, AstraZeneca, Bristol-Myers Squibb, Dendreon.
02 Feb 2023 09:20 GMT
… ., AstraZeneca, Bristol-Myers Squibb Company, Dendreon Pharmaceuticals LLC., F. Hoffmann-La … both value and volume
‣ Market shares and strategies of key players …
-
Global Cellular Immunotherapy Market (2022 to 2031) - Featuring Novartis, Gilead Sciences and Dendreon Pharmaceuticals Among Others
22 Mar 2022 10:31 GMT
… country breakdowns, competitive landscape, market shares, trends and strategies for this … nature of the market, market shares, and a description of the … Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co …
-
Valeant says wait one more year for turnaround; shares fall
28 Feb 2018 15:39 GMT
… .
The Canada-based drugmaker’s shares fell more than 10 percent … .
Valeant has already divested its Dendreon cancer treatment unit as well … drugmaker’s U.S.-listed shares fell to $16.27 in …
-
Why Valeant Pharmaceuticals Shares Are Backing Way Off
28 Feb 2018 16:11 GMT
… brands (CeraVe, AcneFree and AMBI), Dendreon Pharmaceuticals, iNova Pharmaceuticals, Obagi Medical … plan – the transformation of Valeant.
Shares of Valeant were last seen …
-
Valeant revenue forecast fizzles as competition heats up; shares dip
28 Feb 2018 13:46 GMT
… .
Valeant has already divested its Dendreon cancer treatment unit as well … drugmaker’s U.S.-listed shares fell 9 percent to $16 …
-
Valeant says it will exceed debt repayment target, shares surge
08 Aug 2017 15:53 GMT
… targeted, news that pushed its shares up 9 percent.
The company … assets including cancer treatment unit Dendreon Pharmaceuticals, Obagi Medical Products and … Tampa, Florida.
U.S.-listed shares of the Laval, Quebec-based …
-
Valeant pays down $811 million of term loans, shares rise
10 Jul 2017 11:21 GMT
Valeant Pharmaceuticals International Inc. shares
VRX, -2.23%
jumped 1. … of the recent sale of Dendreon Pharmaceuticals LLC to pay off … 18 months of August 2016. Shares have gained 12% in 2017 …
-
Valeant shares hit 2017 high following Dendreon sale
29 Jun 2017 17:10 GMT
LAVAL, Que. -- Shares in Valeant Pharmaceuticals hit … its Dendreon subsidiary for US$819.9 million cash.
Valeant shares traded … Proceeds from the sale of Dendreon Pharmaceuticals to China-based Sanpower … loan.
Valeant's shares remains far below their value …
-
Valeant shares retreat from 2017 high following Dendreon sale
29 Jun 2017 20:05 GMT
… completed the sale of its Dendreon subsidiary for US$819. … New York stock markets.
Its shares were briefly below Wednesday…
Proceeds from the sale of Dendreon Pharmaceuticals to China-based Sanpower … loan.
Valeant's shares remain far below their value …
-
Valeant shares hit 2017 high on completion of US$819.9 million sale of Dendreon
29 Jun 2017 15:44 GMT
LAVAL, Que. — Shares in Valeant Pharmaceuticals hit … its Dendreon subsidiary for US$819.9 million cash.
Valeant shares traded …
Proceeds from the sale of Dendreon Pharmaceuticals to China-based Sanpower … loan.
Valeant's shares remains far below their value …
About
© 1995-2025